ACTA NEUROLOGICA SCANDINAVICA

Scope & Guideline

Exploring the Frontiers of Neuroscience

Introduction

Welcome to the ACTA NEUROLOGICA SCANDINAVICA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ACTA NEUROLOGICA SCANDINAVICA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0001-6314
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1961 to 2024
AbbreviationACTA NEUROL SCAND / Acta Neurol. Scand.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

ACTA NEUROLOGICA SCANDINAVICA focuses on advancing the field of neurology through the publication of original research articles, reviews, and case reports that address various neurological disorders. The journal aims to provide a platform for innovative studies that enhance our understanding of neurological conditions and improve clinical practices.
  1. Neurological Disorders Research:
    The journal covers a wide range of neurological disorders, including but not limited to epilepsy, multiple sclerosis, stroke, and neurodegenerative diseases. This focus allows for a comprehensive understanding of the complexities and treatment challenges associated with these conditions.
  2. Clinical and Translational Studies:
    ACTA NEUROLOGICA SCANDINAVICA emphasizes clinical studies that bridge laboratory research and patient care. This includes trials on new therapeutic interventions, observational studies, and cohort studies that provide insights into treatment outcomes and disease progression.
  3. Neuroimaging and Biomarkers:
    The journal publishes research related to neuroimaging techniques and biomarker studies that aim to improve diagnostic accuracy and prognostic assessments in various neurological disorders.
  4. Quality of Life and Patient-Centered Research:
    A significant focus on understanding the quality of life and psychosocial aspects of living with neurological conditions, reflecting a patient-centered approach to neurological healthcare.
  5. Epidemiological Studies:
    The journal includes epidemiological research that explores the prevalence, incidence, and risk factors associated with neurological diseases, contributing to public health knowledge and policy.
Recent publications in ACTA NEUROLOGICA SCANDINAVICA reflect evolving interests and trends within the field of neurology. This section highlights emerging themes that have gained traction in the journal's recent issues.
  1. COVID-19 and Neurological Implications:
    There is an increasing focus on the neurological implications of COVID-19, including studies on post-viral syndromes, neurological sequelae, and the impact of the pandemic on patients with pre-existing neurological conditions.
  2. Telemedicine and Digital Health:
    Research exploring the role of telemedicine and digital health interventions in managing neurological conditions is on the rise. This includes studies on remote monitoring, tele-rehabilitation, and the use of digital tools to enhance patient care.
  3. Quality of Life and Mental Health in Neurology:
    An emerging trend is the focus on quality of life and mental health outcomes for patients with neurological disorders. Research is increasingly addressing the psychosocial aspects of these conditions, including fatigue, depression, and cognitive impairment.
  4. Neuroimaging Advances:
    There is a growing interest in advanced neuroimaging techniques and their applications in understanding neurological diseases. Studies utilizing machine learning and artificial intelligence for neuroimaging analysis are becoming more prevalent.
  5. Personalized Medicine Approaches:
    The journal is seeing an increase in studies that explore personalized medicine approaches in neurology, including genetic profiling and tailored treatment strategies for neurological disorders.

Declining or Waning

While ACTA NEUROLOGICA SCANDINAVICA has maintained a strong focus on several key areas, there are certain themes and methodologies that appear to be declining in prominence over recent years. This section identifies those waning scopes.
  1. Basic Science and Animal Studies:
    There has been a noticeable decrease in the publication of basic science research and animal studies. The journal is increasingly prioritizing clinical applications and patient-centered research, reflecting a shift towards studies that directly impact patient care.
  2. Historical and Review Articles:
    Although still relevant, the number of historical perspectives and extensive review articles has diminished. The journal seems to favor original research that presents new findings and methodologies over comprehensive literature reviews.
  3. Pharmacological Studies:
    Research focused solely on pharmacological treatments, particularly those that do not incorporate clinical outcomes or patient experiences, has seen a decline. The trend is moving towards studies that integrate pharmacology with real-world clinical data.

Similar Journals

Annals of Clinical and Translational Neurology

Where Cutting-edge Research Meets Patient Impact
Publisher: WILEYISSN: 2328-9503Frequency: 12 issues/year

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

EUROPEAN JOURNAL OF NEUROLOGY

Elevating Knowledge in Neurohealth and Clinical Practice.
Publisher: WILEYISSN: 1351-5101Frequency: 12 issues/year

EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.

REVUE NEUROLOGIQUE

Exploring the Frontiers of Neurological Research
Publisher: MASSON EDITEURISSN: 0035-3787Frequency: 10 issues/year

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

NEUROLOGIC CLINICS

Elevating understanding through rigorous research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Neurology and Clinical Neuroscience

Advancing the frontiers of neurology and clinical practice.
Publisher: WILEYISSN: 2049-4173Frequency: 6 issues/year

Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.

NEUROLOGY

Fostering excellence in the study of neurological disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

NEUROLOGICAL RESEARCH

Connecting Researchers to the Heart of Neurology
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

PRACTICAL NEUROLOGY

Bridging Research and Practice in Neurology
Publisher: BMJ PUBLISHING GROUPISSN: 1474-7758Frequency: 6 issues/year

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

Neurodegenerative Diseases

Advancing understanding of neurodegenerative disorders.
Publisher: KARGERISSN: 1660-2854Frequency: 4 issues/year

Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.

EUROPEAN NEUROLOGY

Advancing the Frontiers of Neurological Science
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.